The deadline for health plans and health insurance issuers to submit their second prescription drug data collection (RxDC) report is June 1, 2023.
RxDC reports must be submitted through an online portal maintained by the Centers for Medicare and Medicaid Services. The agency’s RxDC website provides updated reporting instructions and other reporting resources.
The first RxDC report was due by December 27, 2022 (covering data for 2020 and 2021); however, federal agencies provided a submission grace period through January 31, 2023. The second RxDC report is due by June 1, 2023, and must include data for 2022.
Health plans may use a third party—such as an issuer, TPA or PBM—to prepare and submit the RxDC report on their behalf. To do this, a plan must enter into a written agreement with the third party to address this reporting responsibility. Health plans are not prohibited from submitting RxDC reports on their own, but it is expected
that most employers will rely on third parties to prepare and submit the reports.